EP1433793A4
(en)
*
|
2001-09-13 |
2006-01-25 |
Inst Antibodies Co Ltd |
Method of constructing camel antibody library
|
JP2005289809A
(en)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
Mutant heavy-chain antibody
|
AU2003239966B9
(en)
*
|
2002-06-03 |
2010-08-26 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
EP1585767A2
(en)
*
|
2003-01-16 |
2005-10-19 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
US7329725B1
(en)
|
2003-10-29 |
2008-02-12 |
Nastech Pharmaceutical Company Inc. |
Phage displayed Trp cage ligands
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
WO2005090404A2
(en)
*
|
2004-03-19 |
2005-09-29 |
Zelos Therepeutics, Inc. |
Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth)
|
US7785903B2
(en)
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
DK1836500T3
(en)
|
2005-01-14 |
2010-11-01 |
Ablynx Nv |
Methods and assays to distinguish between different types of diseases and disorders characterized by thrombocytopenia and / or by spontaneous interaction between von Willbrand factor 8vWF) and platelets
|
CA2599465A1
(en)
|
2005-03-11 |
2006-09-14 |
Syngenta Limited |
Antibody based rodenticide
|
HUE045710T2
(en)
|
2005-05-18 |
2020-01-28 |
Ablynx Nv |
Improved nanobodies tm against tumor necrosis factor-alpha
|
BRPI0609797B8
(en)
|
2005-05-20 |
2021-05-25 |
Ablynx Nv |
improved nanobodies for the treatment of aggregation-mediated disorders
|
DE102005023617A1
(en)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Method for mixing colors in a display
|
CA2615744C
(en)
|
2005-07-21 |
2018-03-27 |
Stichting Katholieke Universiteit |
Plexin d1 as a target for tumor diagnosis and therapy
|
CA2625951A1
(en)
|
2005-09-01 |
2007-03-08 |
National Research Council Of Canada |
Anti-apoptotic protein antibodies
|
EP2465870A1
(en)
|
2005-11-07 |
2012-06-20 |
Genentech, Inc. |
Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
|
US7704953B2
(en)
*
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
US8703136B2
(en)
|
2006-10-10 |
2014-04-22 |
Regenesance B.V. |
Complement inhibition for improved nerve regeneration
|
EP2115004A2
(en)
|
2006-12-19 |
2009-11-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
US20100129437A1
(en)
|
2007-03-23 |
2010-05-27 |
Bbb Holding B.V. |
Targeted intracellular delivery of antiviral agents
|
EP2008666A1
(en)
*
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
|
US10214588B2
(en)
|
2007-07-03 |
2019-02-26 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
|
US8426565B2
(en)
*
|
2007-08-30 |
2013-04-23 |
Walter And Eliza Hall Institute Of Medical Research |
Dendritic cell marker and uses thereof
|
AU2008328779B2
(en)
|
2007-11-27 |
2014-06-05 |
Ablynx N.V. |
Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
|
WO2009109572A2
(en)
*
|
2008-03-03 |
2009-09-11 |
Ablynx Nv |
Monovalent phage display of single variable domains
|
CA2717015A1
(en)
|
2008-03-05 |
2009-09-11 |
Ablynx Nv |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
US9908943B2
(en)
|
2008-04-03 |
2018-03-06 |
Vib Vzw |
Single domain antibodies capable of modulating BACE activity
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
DK2281005T3
(en)
|
2008-04-03 |
2014-02-24 |
Vib Vzw |
Single domain antibodies able to modulate bace1 activity
|
EP2260058A2
(en)
|
2008-04-07 |
2010-12-15 |
Ablynx N.V. |
Single variable domains against the notch pathways
|
AU2009237662A1
(en)
|
2008-04-17 |
2009-10-22 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
KR20110020825A
(en)
|
2008-05-16 |
2011-03-03 |
아블린쓰 엔.브이. |
Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
|
LT2285408T
(en)
|
2008-06-05 |
2019-01-25 |
Ablynx N.V. |
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
|
US8444976B2
(en)
|
2008-07-02 |
2013-05-21 |
Argen-X B.V. |
Antigen binding polypeptides
|
AU2009329501B2
(en)
|
2008-12-19 |
2015-11-26 |
Ablynx N.V. |
Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4
|
US20120021405A1
(en)
*
|
2009-01-26 |
2012-01-26 |
Baylor College Of Medicine |
Single Chain Antibody for the Detection of Noroviruses
|
EP2403873A1
(en)
|
2009-03-05 |
2012-01-11 |
Ablynx N.V. |
Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
EP3828201A1
(en)
|
2009-04-30 |
2021-06-02 |
Ablynx N.V. |
Method for the production of domain antibodies
|
HUE051430T2
(en)
|
2009-07-10 |
2021-03-01 |
Ablynx Nv |
Method for the production of variable domains
|
AU2010289677B2
(en)
|
2009-09-03 |
2014-07-31 |
Merck Sharp & Dohme Llc |
Anti-GITR antibodies
|
EP2473527B1
(en)
|
2009-09-03 |
2016-11-30 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
PT2491056T
(en)
|
2009-10-22 |
2021-10-26 |
Univ Of Twente |
Vhh for application in tissue repair, organ regeneration, organ replacement and tissue engineering
|
US20120321640A1
(en)
|
2009-12-01 |
2012-12-20 |
Ablynx N.V. |
Von willebrand factor specific binding agents and uses thereof
|
WO2011073180A1
(en)
|
2009-12-14 |
2011-06-23 |
Ablynx N.V. |
Single variable domain antibodies against ox40l, constructs and therapeutic use
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
JP2013518853A
(en)
|
2010-02-05 |
2013-05-23 |
アブリンクス エン.ヴェー. |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides containing the same
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
CN102753148B
(en)
|
2010-02-11 |
2018-01-26 |
埃博灵克斯股份有限公司 |
For preparing the method and composition of aerosol
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
US8877188B2
(en)
|
2010-05-04 |
2014-11-04 |
The Brigham And Women's Hospital, Inc. |
Detection and treatment of non-dermal fibrosis
|
AU2011248184B2
(en)
|
2010-05-04 |
2015-12-17 |
Board Of Regents, The University Of Texas System |
Detection and treatment of fibrosis
|
AU2011254557B2
(en)
|
2010-05-20 |
2015-09-03 |
Ablynx Nv |
Biological materials related to HER3
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
GB201014715D0
(en)
|
2010-09-06 |
2010-10-20 |
Vib Vzw |
Nanobodies stabilizing functional conformational states of GPCRS
|
HUE036251T2
(en)
|
2010-08-26 |
2018-06-28 |
Agrosavfe N V |
Chitinous polysaccharide antigen binding proteins
|
DK2632946T3
(en)
|
2010-10-29 |
2018-03-12 |
Ablynx Nv |
PROCEDURE FOR MANUFACTURING VARIABLE IMMUNGLOBULIN SINGLE DOMAINS
|
PT2691415T
(en)
|
2011-03-28 |
2018-10-19 |
Ablynx Nv |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
UA117218C2
(en)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
|
EP2707382B1
(en)
|
2011-05-09 |
2019-07-17 |
Ablynx NV |
Method for the production of immunoglobulin single variable domains
|
WO2012163887A1
(en)
|
2011-05-27 |
2012-12-06 |
Ablynx Nv |
Inhibition of bone resorption with rankl binding peptides
|
ES2662372T3
(en)
|
2011-06-21 |
2018-04-06 |
Vib Vzw |
Binding domains directed against GPCR complexes: G protein and uses derived therefrom
|
EP2723772A1
(en)
|
2011-06-23 |
2014-04-30 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against ige
|
DK2747782T3
(en)
|
2011-09-23 |
2018-04-23 |
Ablynx Nv |
Long-term inhibition of interleukin-6-mediated signal transmission
|
US10112988B2
(en)
|
2012-01-09 |
2018-10-30 |
Icb International, Inc. |
Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
|
US10112987B2
(en)
|
2012-01-09 |
2018-10-30 |
Icb International, Inc. |
Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
|
EP2617732A1
(en)
|
2012-01-19 |
2013-07-24 |
Vib Vzw |
Tools and methods for expression of membrane proteins
|
CA2874309C
(en)
|
2012-05-24 |
2021-06-15 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
EP3590578A1
(en)
|
2013-02-05 |
2020-01-08 |
VIB vzw |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
AU2014229952B2
(en)
|
2013-03-15 |
2018-10-04 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
|
WO2014191146A1
(en)
|
2013-04-29 |
2014-12-04 |
Agrosavfe N.V. |
Agrochemical compositions comprising antibodies binding to sphingolipids
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
EP3066120B1
(en)
*
|
2013-11-04 |
2018-10-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Synthetic single domain antibody
|
EP2883883A1
(en)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutic targets and agents useful in treating ischemia reperfusion injury
|
JP6687525B2
(en)
|
2014-01-30 |
2020-04-22 |
ブイアイビー ブイゼットダブリュVib Vzw |
Opioid receptor binding agents and uses thereof
|
KR102355310B1
(en)
*
|
2014-03-06 |
2022-01-24 |
내셔날 리서치 카운실 오브 캐나다 |
Insulin-like growth factor 1 receptor-specific antibodies and uses thereof
|
JP6541236B2
(en)
*
|
2014-03-06 |
2019-07-10 |
ナショナル リサーチ カウンシル オブ カナダ |
Insulin-like growth factor 1 receptor specific antibodies and their use
|
EP3114142B1
(en)
*
|
2014-03-06 |
2019-06-05 |
National Research Council of Canada |
Insulin-like growth factor 1 receptor -specific antibodies and uses thereof
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
DK3174559T3
(en)
|
2014-07-29 |
2022-12-05 |
Univ Brussel Vrije |
Radiolabeled antibody fragments for use in the prevention and/or treatment of cancer
|
US20180036442A1
(en)
|
2014-07-29 |
2018-02-08 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
CA2966548A1
(en)
|
2014-11-05 |
2016-05-12 |
Agrosavfe Nv |
Transgenic plant comprising a polynucleotide encoding a variable domain of heavy-chain antibody
|
CN107406497A
(en)
|
2014-12-19 |
2017-11-28 |
埃博灵克斯股份有限公司 |
The nano antibody dimer of cysteine connection
|
EP3288584A2
(en)
|
2015-04-30 |
2018-03-07 |
President and Fellows of Harvard College |
Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders
|
AU2016263808B2
(en)
|
2015-05-21 |
2019-01-03 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
EP3325020B1
(en)
|
2015-07-17 |
2022-01-12 |
Vrije Universiteit Brussel |
Radiolabelled antibody fragments for use in treating cancer
|
CN105384825B
(en)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
A kind of bispecific chimeric antigen receptor and its application based on single domain antibody
|
US20170059561A1
(en)
*
|
2015-08-28 |
2017-03-02 |
The Florida International University Board Of Trustees |
Thermally Stable Electrochemical Sensor With Long Shelf-Life
|
BR112018010802A2
(en)
|
2015-11-27 |
2018-11-27 |
Ablynx Nv |
cd40l inhibiting polypeptides
|
CN116813799A
(en)
|
2016-02-05 |
2023-09-29 |
奥里尼斯生物科学私人有限公司 |
CLEC9A binding agents and uses thereof
|
CA3016849A1
(en)
|
2016-03-07 |
2017-09-14 |
Vib Vzw |
Cd20 binding single domain antibodies
|
US11186641B2
(en)
|
2016-03-17 |
2021-11-30 |
Oslo Universitetssykehus Hf |
Fusion proteins targeting tumour associated macrophages for treating cancer
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
CN107304419A
(en)
*
|
2016-04-22 |
2017-10-31 |
中国农业科学院兰州兽医研究所 |
The yeast cDNA library and its construction method and purposes of a kind of swine fever virus resistant VHH antibody
|
WO2017182603A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
CA3022697A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
CN105821480A
(en)
*
|
2016-05-03 |
2016-08-03 |
中国农业科学院兰州兽医研究所 |
Anti-orf virus two-humped camel VHH heavy-chain single-domain antibody cDNA library and preparation method thereof
|
CN109563141A
(en)
|
2016-05-13 |
2019-04-02 |
奥里尼斯生物科学公司 |
To the therapeutic targeting of cellular structures
|
CA3024683A1
(en)
|
2016-05-20 |
2017-11-23 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment cd3 binding proteins
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
KR102530742B1
(en)
|
2016-05-20 |
2023-05-09 |
하푼 테라퓨틱스, 인크. |
single domain serum albumin binding protein
|
EP3463482B1
(en)
|
2016-06-07 |
2021-10-06 |
The Brigham and Women's Hospital, Inc. |
Methods relating to t peripheral helper cells in autoantibody-associated conditions
|
GB201610198D0
(en)
|
2016-06-10 |
2016-07-27 |
Ucb Biopharma Sprl |
Anti-ige antibodies
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
WO2018068201A1
(en)
|
2016-10-11 |
2018-04-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against ctla-4
|
KR102665596B1
(en)
|
2016-11-16 |
2024-05-14 |
아블린쓰 엔.브이. |
T cell recruiting polypeptide capable of binding CD123 and TCR alpha/beta
|
AU2017363302A1
(en)
|
2016-11-23 |
2019-06-27 |
Harpoon Therapeutics, Inc. |
PSMA targeting trispecific proteins and methods of use
|
KR20210087108A
(en)
|
2016-11-23 |
2021-07-09 |
하푼 테라퓨틱스, 인크. |
Prostate specific membrane antigen binding protein
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
CN110382522A
(en)
*
|
2017-01-30 |
2019-10-25 |
加拿大国家研究委员会 |
Blood-brain barrier passes through compound and application thereof
|
EP3577133A1
(en)
|
2017-02-06 |
2019-12-11 |
Orionis Biosciences NV |
Targeted chimeric proteins and uses thereof
|
JP7186401B2
(en)
|
2017-02-28 |
2022-12-09 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
Means and methods for oral delivery of proteins
|
EP3589662A4
(en)
|
2017-02-28 |
2020-12-30 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
EP3612648A1
(en)
|
2017-04-18 |
2020-02-26 |
Université Libre de Bruxelles |
Biomarkers and targets for proliferative diseases
|
US11891451B2
(en)
|
2017-05-11 |
2024-02-06 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
EP3621994A4
(en)
|
2017-05-12 |
2020-12-30 |
Harpoon Therapeutics, Inc. |
Mesothelin binding proteins
|
BR112019023856A2
(en)
|
2017-05-12 |
2020-06-09 |
Harpoon Therapeutics Inc |
triespecific proteins targeting msln and methods of use
|
WO2018222587A1
(en)
|
2017-05-30 |
2018-12-06 |
The Regents Of The University Of California |
NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif)
|
TWI826376B
(en)
|
2017-06-02 |
2023-12-21 |
德商麥克專利有限公司 |
Polypeptides binding adamts5, mmp13 and aggrecan
|
MX2019014400A
(en)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Adamts binding immunoglobulins.
|
WO2018220225A1
(en)
|
2017-06-02 |
2018-12-06 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
BR112019025097A2
(en)
|
2017-06-02 |
2020-07-28 |
Merck Patent Gmbh |
mmp13-binding immunoglobulins
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
Chimeric antibody immune effctor cell engagers and methods of use thereof
|
WO2019016237A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
BR112020007196A2
(en)
|
2017-10-13 |
2020-12-01 |
Harpoon Therapeutics, Inc. |
triespecific proteins and methods of use
|
BR112020007249B1
(en)
|
2017-10-13 |
2022-11-22 |
Harpoon Therapeutics, Inc |
B-CELL MATURATION ANTIGEN-BINDING ROUTINE, MULTISPECIFIC BINDING PROTEIN AND USE OF SUCH PROTEINS
|
EP3704160A1
(en)
|
2017-10-31 |
2020-09-09 |
VIB vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
CA3082280A1
(en)
|
2017-12-28 |
2019-07-04 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against tigit
|
JP7366908B2
(en)
|
2018-01-15 |
2023-10-23 |
ナンジン レジェンド バイオテック カンパニー,リミテッド |
Single domain antibodies against PD-1 and variants thereof
|
CA3090406A1
(en)
|
2018-02-05 |
2019-08-08 |
Orionis Biosciences, Inc. |
Fibroblast binding agents and use thereof
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
CA3092421A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
JP7390729B2
(en)
|
2018-03-23 |
2023-12-04 |
ユニヴェルシテ リブル ドゥ ブリュッセル |
Wnt signaling agonist molecules
|
JP2021519093A
(en)
|
2018-03-27 |
2021-08-10 |
ユーエムシー ユトレヒト ホールディング ビー.ブイ. |
Targeted thrombolysis for the treatment of microvascular thrombosis
|
SG11202006674QA
(en)
|
2018-03-30 |
2020-08-28 |
Nanjing Legend Biotech Co Ltd |
Single-domain antibodies against lag-3 and uses thereof
|
AU2019346466A1
(en)
|
2018-09-25 |
2021-05-20 |
Harpoon Therapeutics, Inc. |
DLL3 binding proteins and methods of use
|
WO2020221888A1
(en)
|
2019-04-30 |
2020-11-05 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
CN114245806A
(en)
|
2019-05-14 |
2022-03-25 |
哈普恩治疗公司 |
Epcam binding proteins and methods of use
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
WO2020239934A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
CN110981958B
(en)
*
|
2019-08-23 |
2020-10-20 |
四川大学华西医院 |
PD-L1 antibody
|
EP4048703A1
(en)
|
2019-10-21 |
2022-08-31 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
CN110776564B
(en)
*
|
2019-10-30 |
2022-02-08 |
西北农林科技大学 |
Two-strain anti-newcastle disease virus nano antibody and expression preparation method and application thereof
|
US20220411495A1
(en)
|
2019-11-27 |
2022-12-29 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
EP4077372A1
(en)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanobody exchange chromatography
|
CN114901301A
(en)
*
|
2019-12-20 |
2022-08-12 |
免疫医疗有限责任公司 |
Compositions and methods for treating cancer with chimeric antigen receptors targeting glypican 3
|
CA3164037A1
(en)
|
2020-01-08 |
2021-07-15 |
Synthis Therapeutics, Inc. |
Alk5 inhibitor conjugates and uses thereof
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
CA3170833A1
(en)
|
2020-02-21 |
2021-08-26 |
Harpoon Therapeutics, Inc. |
Flt3 binding proteins and methods of use
|
JP2023514654A
(en)
|
2020-02-25 |
2023-04-06 |
ブイアイビー ブイゼットダブリュ |
Allosteric regulator of leucine-rich repeat kinase 2
|
MX2022012376A
(en)
|
2020-03-31 |
2023-02-15 |
Biotalys NV |
Anti-fungal polypeptides.
|
US20230279115A1
(en)
|
2020-04-22 |
2023-09-07 |
Mabwell (shanghai) Bioscience Co., Ltd. |
Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative thereof
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
CA3182339A1
(en)
|
2020-05-20 |
2021-11-25 |
Institut Curie |
Synthetic single domain library
|
TW202214844A
(en)
|
2020-06-17 |
2022-04-16 |
美商健生生物科技公司 |
Materials and methods for the manufacture of pluripotent stem cells
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
BR112023000400A2
(en)
|
2020-07-10 |
2023-03-21 |
Shanghai Jemincare Pharmaceutical Co Ltd |
ENGINEERED ANTI-IGE ANTIBODY AND ITS APPLICATION
|
EP4189060A1
(en)
|
2020-07-31 |
2023-06-07 |
Biotalys NV |
Expression host
|
CA3196737A1
(en)
|
2020-09-24 |
2022-03-31 |
Massimiliano Mazzone |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
KR20230074527A
(en)
|
2020-09-25 |
2023-05-30 |
아블린쓰 엔.브이. |
Polypeptides comprising an immunoglobulin single variable domain targeting IL-13 and OX40L
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
WO2022117572A2
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
An ltbr agonist in combination therapy against cancer
|
US11897951B2
(en)
|
2020-12-18 |
2024-02-13 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
US20240052044A1
(en)
|
2020-12-24 |
2024-02-15 |
Vib Vzw |
Non-blocking human ccr8 binders
|
US20240076391A1
(en)
|
2020-12-24 |
2024-03-07 |
Oncurious Nv |
Human ccr8 binders
|
CA3206125A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
WO2022156908A1
(en)
|
2021-01-25 |
2022-07-28 |
Vrije Universiteit Brussel |
Method for preparing a lyophilized composition
|
WO2022157373A1
(en)
|
2021-01-25 |
2022-07-28 |
Vrije Universiteit Brussel |
Compositions and kits for in vivo imaging of cardiac sarcoidosis
|
WO2022156907A1
(en)
|
2021-01-25 |
2022-07-28 |
Vrije Universiteit Brussel |
Method and kit for labeling a biomolecule with one or more detectable labels, including a radiolabel
|
CA3207548A1
(en)
|
2021-02-05 |
2022-08-11 |
Xavier Saelens |
Sarbecovirus binders
|
CN117794566A
(en)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
Sha Bei viral binding agents
|
EP4294407A1
(en)
|
2021-02-17 |
2023-12-27 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
KR20220118962A
(en)
|
2021-02-19 |
2022-08-26 |
(주)샤페론 |
Single domain antibodies against PD-L1 and use thereof
|
WO2022175532A1
(en)
|
2021-02-19 |
2022-08-25 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
JP2024509766A
(en)
|
2021-02-19 |
2024-03-05 |
シャペロン インク. |
Bispecific single domain antibodies against PD-L1 and CD47 and their uses
|
AU2022224636A1
(en)
|
2021-02-19 |
2023-09-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies that neutralize sars-cov-2
|
WO2022177392A1
(en)
|
2021-02-19 |
2022-08-25 |
(주)샤페론 |
Single domain antibody against cd47 and use thereof
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
US20230174651A1
(en)
|
2021-06-23 |
2023-06-08 |
Janssen Biotech, Inc. |
Materials and methods for hinge regions in functional exogenous receptors
|
EP4359421A1
(en)
|
2021-06-23 |
2024-05-01 |
Vib Vzw |
Means and methods for selection of specific binders
|
CN117580865A
(en)
|
2021-06-29 |
2024-02-20 |
山东先声生物制药有限公司 |
CD16 antibodies and uses thereof
|
EP4377352A2
(en)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
EP4378954A1
(en)
|
2021-07-30 |
2024-06-05 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-pvrig/anti-tigit bispecific antibody and application
|
WO2023057508A1
(en)
|
2021-10-05 |
2023-04-13 |
Vrije Universiteit Brussel |
Fluorescently labeled immunoglobulin single variable domai ns
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
WO2023111266A1
(en)
|
2021-12-17 |
2023-06-22 |
Ablynx Nv |
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TCRαβ, CD33 AND CD123
|
WO2023135198A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
WO2023148291A1
(en)
|
2022-02-02 |
2023-08-10 |
Biotalys NV |
Methods for genome editing
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
WO2023198848A1
(en)
|
2022-04-13 |
2023-10-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
WO2023213751A1
(en)
|
2022-05-02 |
2023-11-09 |
Umc Utrecht Holding B.V |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
WO2023215888A2
(en)
*
|
2022-05-06 |
2023-11-09 |
The Children's Medical Center Corporation |
Binding agents for bcl11a and methods of use thereof
|
WO2023222825A1
(en)
|
2022-05-18 |
2023-11-23 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
WO2024008755A1
(en)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Blood-cerebrospinal fluid barrier crossing antibodies
|
WO2024018426A1
(en)
|
2022-07-22 |
2024-01-25 |
Janssen Biotech, Inc. |
Enhanced transfer of genetic instructions to effector immune cells
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
EP4349374A1
(en)
|
2022-10-05 |
2024-04-10 |
Vrije Universiteit Brussel |
Anti-urokinase plasminogen activator receptor immunoglobulin single variable domains
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
WO2024105091A1
(en)
|
2022-11-15 |
2024-05-23 |
Imec Vzw |
Method and system for droplet manipulation
|